July 17, 2013Open Access
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial
Key Result
A novel prognostic risk score was created to evaluate the efficacy of eplerenone across different risk categories in patients with systolic heart failure and mild symptoms.
Main Result
Absolute Event Rate: 0% vs 0%
Abstract
Our objective was to create a simple prognostic risk score for patients with systolic heart failure and mild symptoms. We then assessed the efficacy of eplerenone across different categories of risk.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
T
Timothy Collier
Preventive Cardiology
Stuart Pocock
General Cardiology
John J.V. McMurray
British Heart Foundation
Journals
European Heart Journal
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
Actions
Institutions
University of Michigan
Inserm
Monash University
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...